Global Contrast-Enhanced Ultrasound Market Size By Type (Non-targeted contrast-enhanced ultrasound, Targeted contrast-enhanced ultrasound), By Application (Hospitals, Clinics), By Region, And Segment...

The Global Contrast-Enhanced Ultrasound (CEUS) Market was valued at USD 1.9 billion in 2023 and is projected to surpass USD 4.1 billion by 2031, growing at a CAGR of 10.2% during the forecast period of 2023–2031. CEUS is gaining traction as a cost-effective, non-invasive imaging technique used across diverse clinical applications including cardiology, oncology, and nephrology. This technology utilizes microbubble contrast agents to enhance the visualization of blood flow and organ perfusion in real-time, offering valuable insights in diagnosis and treatment planning. Increasing adoption in diagnostic centers and hospitals, along with technological advancements in ultrasound systems, is expected to drive substantial market growth globally.

Drivers:

1. Rising Prevalence of Chronic Diseases:

The increasing global burden of cardiovascular disorders, liver diseases, and cancer is significantly contributing to the demand for advanced diagnostic imaging. CEUS provides precise, real-time visualization of microvascular blood flow, aiding in early diagnosis and monitoring.

2. Technological Advancements in Ultrasound Imaging:

Continuous innovations such as 3D/4D ultrasound, portable devices, and AI-integrated imaging platforms are enhancing the capabilities and reliability of CEUS, encouraging its widespread adoption across clinical settings.

3. Growing Preference for Non-Invasive Procedures:

Healthcare providers and patients are increasingly favoring CEUS over more invasive diagnostic methods like biopsies or CT scans due to its minimal side effects, absence of ionizing radiation, and cost-effectiveness.

Restraints:

1. Limited Awareness and Training:

In many regions, especially low- and middle-income countries, limited awareness among clinicians and radiologists about CEUS capabilities can restrict its adoption.

2. Regulatory and Reimbursement Challenges:

Lack of uniform reimbursement policies and stringent regulatory frameworks around contrast agents in some countries can impede market penetration.

Opportunity:

1. Expanding Applications in Oncology and Pediatrics:

The use of CEUS in detecting liver tumors, kidney lesions, and pediatric imaging is opening new avenues for market growth. Its safety profile and diagnostic accuracy make it suitable for vulnerable populations.

2. Integration with AI and Machine Learning:

Emerging integration of CEUS platforms with artificial intelligence and machine learning is expected to enhance diagnostic precision, automate image interpretation, and boost clinical outcomes.

3. Market Expansion in Emerging Economies:

Countries in Asia-Pacific and Latin America are investing in healthcare infrastructure, offering lucrative opportunities for CEUS adoption, especially in rural and semi-urban healthcare facilities.

Market by System Type Insights:

Based on system type, the Diagnostic Ultrasound Systems segment held the largest market share in 2023. These systems are widely used in hospitals and imaging centers for their versatility, accuracy, and real-time imaging capabilities. The Portable Ultrasound Devices segment is expected to witness the highest CAGR during the forecast period, driven by rising point-of-care diagnostics, emergency care applications, and use in resource-limited settings.

Market by End-use Insights:

The Hospitals & Clinics segment dominated the CEUS market in 2023 due to the high volume of diagnostic procedures and advanced imaging infrastructure. Diagnostic Imaging Centers are expected to grow rapidly, benefiting from increasing outpatient diagnostic services, reduced cost burden, and faster patient turnaround.

Market by Regional Insights:

North America led the global market in 2023, driven by advanced healthcare infrastructure, high disease awareness, and early adoption of cutting-edge technologies. However, Asia-Pacific is projected to witness the fastest growth through 2031, fueled by large patient populations, rising investments in healthcare, and growing acceptance of CEUS for routine diagnostics.

Competitive Scenario:

Key players in the global contrast-enhanced ultrasound market include Bracco Imaging S.p.A., GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Lantheus Medical Imaging, Mindray Medical International Limited, and Samsung Medison Co., Ltd. These companies are focusing on new product launches, regulatory approvals, and geographic expansion.

In 2023, Bracco Imaging received FDA approval for a new-generation ultrasound contrast agent designed to enhance diagnostic performance in liver imaging.

GE HealthCare launched a compact CEUS-integrated device tailored for point-of-care applications in 2024.

Siemens Healthineers announced an AI-powered CEUS software upgrade for enhanced lesion characterization in oncology imaging.

Scope of Work – Global Contrast-Enhanced Ultrasound Market

Report Metric Details

Market Size (2023) USD 1.9 Billion

Projected Market Size (2031) USD 4.1 Billion

CAGR (2023–2031) 10.2%

Market Segments By System Type (Diagnostic, Portable), By End-Use (Hospitals, Clinics)

Growth Drivers Rising chronic diseases, technological innovations, preference for non-invasive imaging

Opportunities AI integration, pediatric/oncology expansion, emerging market penetration

Key Market Developments:

March 2023: Bracco Imaging launched SonVue™, a CEUS agent with improved microbubble stability and longer imaging time.

June 2024: Philips Healthcare introduced CEUS support in its Lumify portable ultrasound system, enhancing point-of-care capabilities.

January 2025: Canon Medical Systems partnered with a major university hospital in Japan to develop AI-integrated CEUS solutions for liver cancer diagnostics.

FAQs:

1) What is the current market size of the Global Contrast-Enhanced Ultrasound Market?

The market was valued at USD 1.9 billion in 2023.

2) What is the major growth driver of the Global Contrast-Enhanced Ultrasound Market?

The major growth driver is the increasing prevalence of chronic diseases coupled with technological advancements in ultrasound imaging.

3) Which is the largest region during the forecast period in the Global Contrast-Enhanced Ultrasound Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow the fastest through 2031.

4) Which segment accounted for the largest market share in the Global Contrast-Enhanced Ultrasound Market?

The Diagnostic Ultrasound Systems segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Contrast-Enhanced Ultrasound Market?

Key players include Bracco Imaging, GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical, Lantheus, and Mindray.